The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
Open accessAbstract
Aspergillus fungi are the cause of an array of diseases affecting humans, animals and plants. The triazole antifungal agents itraconazole, voriconazole, isavuconazole and posaconazole are treatment options against diseases caused by Aspergillus . However, resistance to azoles has recently emerged as a new therapeutic challenge in six continents. Although de novo azole resistance occurs occasionally in patients during azole therapy, the main burden is the aquisition of resistance through the environment. In this setting, the evolution of resistance is attributed to the widespread use of azole-based fungicides. Although ubiquitously distributed, A. fumigatus is not a phytopathogen. However, agricultural fungicides deployed against plant pathogenic moulds such as Fusarium , Mycospaerella and A. flavus also show activity against A. fumigatus in the environment and exposure of non-target fungi is inevitable. Further, similarity in molecule structure between azole fungicides and antifungal drugs results in cross-resistance of A. fumigatus to medical azoles. Clinical studies have shown that two-thirds of patients with azole-resistant infections had no previous history of azole therapy and high mortality rates between 50% and 100% are reported in azole-resistant invasive aspergillosis. The resistance phenotype is associated with key mutations in the cyp51A gene, including TR 34 /L98H, TR 53 and TR 46 /Y121F/T289A resistance mechanisms. Early detection of resistance is of paramount importance and if demonstrated, either with susceptibility testing or through molecular analysis, azole monotherapy should be avoided. Liposomal amphotericin B or a combination of voriconazole and an echinocandin are recomended for azole-resistant aspergillosis. This article is part of the themed issue ‘Tackling emerging fungal threats to animal health, food security and ecosystem resilience’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hussain, H. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmc076105 · Cited by 36
RetractedPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,557
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Denning, D. W., Cadranel, J., Beigelman-Aubry, C., Ader, F., Chakrabarti, A., Blot, S., Ullmann, A. J., Dimopoulos, G., & Lange, C. (2016) · European Respiratory Journal · doi:10.1183/13993003.00583-2015 · Cited by 1,030
Maertens, J. A., Raad, I. I., Marr, K. A., Patterson, T. F., Kontoyiannis, D. P., Cornely, O. A., Bow, E. J., Rahav, G., Neofytos, D., Aoun, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01159-9 · Cited by 1,001
The clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Self-citationAneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050219 · Cited by 727
Self-citationAzole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., & Melchers, W. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70265-8 · Cited by 604
Self-citationVerweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561
Self-citationDiscovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus
O’Gorman, C. M., Fuller, H. T., & Dyer, P. S. (2009) · Nature · doi:10.1038/nature07528 · Cited by 555
Combination Antifungal Therapy for Invasive Aspergillosis: A Randomized Trial
Marr, K. A., Schlamm, H. T., Herbrecht, R., Rottinghaus, S. T., Bow, E. J., Cornely, O. A., Heinz, W. J., Jagannatha, S., Koh, L. P., Kontoyiannis, D. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m13-2508 · Cited by 514
Itraconazole resistance in Aspergillus fumigatus
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 508
Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009
van der Linden, J. W. M., Snelders, E., Kampinga, G. A., Rijnders, B. J. A., Mattsson, E., Debets-Ossenkopp, Y. J., Kuijper, E. J., Van Tiel, F. H., Melchers, W. J. G., & Verweij, P. E. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110226 · Cited by 446
Self-citationAspergillus fumigatus—What Makes the Species a Ubiquitous Human Fungal Pathogen?
Kwon-Chung, K. J., & Sugui, J. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003743 · Cited by 432
Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus
Snelders, E., Camps, S. M. T., Karawajczyk, A., Schaftenaar, G., Kema, G. H. J., van der Lee, H. A., Klaassen, C. H., Melchers, W. J. G., & Verweij, P. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031801 · Cited by 427
Self-citationPossible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
Snelders, E., Huis in 't Veld, R. A. G., Rijs, A. J. M. M., Kema, G. H. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00231-09 · Cited by 423
Self-citationTaccone, F. S., Van den Abeele, A.-M., Bulpa, P., Misset, B., Meersseman, W., Cardoso, T., Paiva, J.-A., Blasco-Navalpotro, M., De Laere, E., Dimopoulos, G., et al. (2015) · Critical Care · doi:10.1186/s13054-014-0722-7 · Cited by 405
Chowdhary, A., Kathuria, S., Xu, J., & Meis, J. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003633 · Cited by 380
Self-citationMultiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Self-citationProspective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus
van der Linden, J. W. M., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., Chryssanthou, E., Mellado, E., Kidd, S. E., Tortorano, A. M., et al. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2106.140717 · Cited by 371
Self-citationFactors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
Nivoix, Y., Velten, M., Letscher‐Bru, V., Moghaddam, A., Natarajan‐Amé, S., Fohrer, C., Lioure, B., Bilger, K., Lutun, P., Marcellin, L., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/592255 · Cited by 342
van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit320 · Cited by 342
Self-citationVerweij, P. E., Ananda-Rajah, M., Andes, D., Arendrup, M. C., Brüggemann, R. J., Chowdhary, A., Cornely, O. A., Denning, D. W., Groll, A. H., Izumikawa, K., et al. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.001 · Cited by 330
Self-citationFraczek, M. G., Bromley, M., Buied, A., Moore, C. B., Rajendran, R., Rautemaa, R., Ramage, G., Denning, D. W., & Bowyer, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt075 · Cited by 315
Denning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313
Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Monk, B. C., Tomasiak, T. M., Keniya, M. V., Huschmann, F. U., Tyndall, J. D. A., O’Connell, J. D., Cannon, R. D., McDonald, J. G., Rodriguez, A., Finer-Moore, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324245111 · Cited by 280
CRYPTIC SPECIATION IN THE COSMOPOLITAN AND CLONAL HUMAN PATHOGENIC FUNGUS ASPERGILLUS FUMIGATUS
Pringle, A., Baker, D. M., Platt, J. L., Wares, J. P., Latgé, J. P., & Taylor, J. W. (2005) · Evolution · doi:10.1111/j.0014-3820.2005.tb01059.x · Cited by 267
Wauters, J., Baar, I., Meersseman, P., Meersseman, W., Dams, K., De Paep, R., Lagrou, K., Wilmer, A., Jorens, P., & Hermans, G. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2673-2 · Cited by 265
Camps, S. M. T., van der Linden, J. W. M., Li, Y., Kuijper, E. J., van Dissel, J. T., Verweij, P. E., & Melchers, W. J. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05088-11 · Cited by 230
Self-citationCamps, S. M. T., Dutilh, B. E., Arendrup, M. C., Rijs, A. J. M. M., Snelders, E., Huynen, M. A., Verweij, P. E., & Melchers, W. J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050034 · Cited by 212
Self-citationSnelders, E., Karawajczyk, A., Schaftenaar, G., Verweij, P. E., & Melchers, W. J. G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01599-09 · Cited by 206
Self-citationChowdhary, A., Kathuria, S., Xu, J., Sharma, C., Sundar, G., Singh, P. K., Gaur, S. N., Hagen, F., Klaassen, C. H., & Meis, J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052871 · Cited by 195
Self-citationChowdhary, A., Kathuria, S., Randhawa, H. S., Gaur, S. N., Klaassen, C. H., & Meis, J. F. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr443 · Cited by 188
Self-citationEmergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany
Steinmann, J., Hamprecht, A., Vehreschild, M. J. G. T., Cornely, O. A., Buchheidt, D., Spiess, B., Koldehoff, M., Buer, J., Meis, J. F., & Rath, P.-M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku566 · Cited by 185
Self-citationBurgel, P.-R., Baixench, M.-T., Amsellem, M., Audureau, E., Chapron, J., Kanaan, R., Honoré, I., Dupouy-Camet, J., Dusser, D., Klaassen, C. H., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05077-11 · Cited by 178
Self-citationAbdolrasouli, A., Rhodes, J., Beale, M. A., Hagen, F., Rogers, T. R., Chowdhary, A., Meis, J. F., Armstrong-James, D., & Fisher, M. C. (2015) · mBio · doi:10.1128/mbio.00536-15 · Cited by 177
Self-citationAspergillus species intrinsically resistant to antifungal agents
Van Der Linden, J. W. M., Warris, A., & Verweij, P. E. (2011) · Medical Mycology · doi:10.3109/13693786.2010.499916 · Cited by 169
Self-citationWiederhold, N. P., Gil, V. G., Gutierrez, F., Lindner, J. R., Albataineh, M. T., McCarthy, D. I., Sanders, C., Fan, H., Fothergill, A. W., & Sutton, D. A. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02478-15 · Cited by 168
Chong, G. M., van de Sande, W. W. J., Dingemans, G., Gaajetaan, G. R., Vonk, A. G., Hayette, M., van Tegelen, D. W. E., Simons, G., & Rijnders, B. J. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03216-14 · Cited by 154
Viscoli, C., Herbrecht, R., Akan, H., Baila, L., Sonet, A., Gallamini, A., Giagounidis, A., Marchetti, O., Martino, R., Meert, L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp355 · Cited by 154
Chowdhary, A., Sharma, C., Hagen, F., & Meis, J. F. G. M. (2014) · Future Microbiology · doi:10.2217/fmb.14.27 · Cited by 152
Self-citationGsaller, F., Hortschansky, P., Furukawa, T., Carr, P. D., Rash, B. M., Capilla, J., Müller, C., Bracher, F., Bowyer, P., Haas, H., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005775 · Cited by 151
Camps, S. M. T., Rijs, A. J. M. M., Klaassen, C. H. W., Meis, J. F. G. M., O’Gorman, C. M., Dyer, P. S., Melchers, W. J. G., & Verweij, P. E. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00335-12 · Cited by 145
Self-citationVerweij, P. E., Zhang, J., Debets, A. J. M., Meis, J. F., van de Veerdonk, F. L., Schoustra, S. E., Zwaan, B. J., & Melchers, W. J. G. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30138-4 · Cited by 140
Self-citationMulti-azole-resistant Aspergillus fumigatus in the environment in Tanzania
Chowdhary, A., Sharma, C., van den Boom, M., Yntema, J. B., Hagen, F., Verweij, P. E., & Meis, J. F. G. M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku259 · Cited by 137
Self-citationArendrup, M. C., Meletiadis, J., Mouton, J. W., Guinea, J., Cuenca‐Estrella, M., Lagrou, K., Howard, S. J., Arendrup, M. C., Meletiadis, J., Howard, S. J., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.017 · Cited by 136
Self-citationChowdhary, A., Sharma, C., Kathuria, S., Hagen, F., & Meis, J. F. G. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00428 · Cited by 121
Self-citationBadali, H., Vaezi, A., Haghani, I., Yazdanparast, S. A., Hedayati, M. T., Mousavi, B., Ansari, S., Hagen, F., Meis, J. F. G. M., & Chowdhary, A. (2013) · Mycoses · doi:10.1111/myc.12089 · Cited by 114
Self-citationWhite, P. L., Posso, R. B., & Barnes, R. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00667-15 · Cited by 113
Verweij, P. E., Dorsthorst, D. T. A. T., Rijs, A. J. M. M., de Vries-Hospers, H. G., & Meis, J. F. G. M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2648-2650.2002 · Cited by 108
Self-citationHigh prevalence of azole resistance inAspergillus fumigatusisolates from high-risk patients
Führen, J., Voskuil, W. S., Boel, C. H. E., Haas, P., Hagen, F., Meis, J. F. G. M., & Kusters, J. G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv177 · Cited by 107
Self-citationRydholm, C., Szakács, G., & Lutzoni, F. M. (2006) · Eukaryotic Cell · doi:10.1128/ec.5.4.650-657.2006 · Cited by 99
Multi‐triazole‐resistant Aspergillus fumigatus infections in Australia
Kidd, S. E., Goeman, E., Meis, J. F. G. M., Slavin, M. A., & Verweij, P. E. (2015) · Mycoses · doi:10.1111/myc.12324 · Cited by 97
Self-citationNationwide Surveillance of Azole Resistance in Aspergillus Diseases
Vermeulen, E., Maertens, J. A., Bel, A. D., Nulens, E., Boelens, J., Surmont, I., Mertens, A., Boel, A., & Lagrou, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00233-15 · Cited by 96
Meneau, I., Coste, A. T., & Sanglard, D. (2016) · Medical Mycology · doi:10.1093/mmy/myw005 · Cited by 91
Chen, Y., Lu, Z., Zhao, J., Zou, Z., Gong, Y., Qu, F., Bao, Z., Qiu, G.-B., Song, M., Zhang, Q., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01005-16 · Cited by 91
Self-citationIn-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole
Dannaoui, É., Persat, F., Monier, M., Borel, E., Piens, M., & Picot, S. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.4.553 · Cited by 86
Ahmad, S., Khan, Z., Hagen, F., & Meis, J. F. G. M. (2014) · Environmental Research · doi:10.1016/j.envres.2014.05.009 · Cited by 75
Self-citationLavergne, R., Morio, F., Favennec, L., Dominique, S., Meis, J. F. G. M., Gargala, G., Verweij, P. E., & Pape, P. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00127-15 · Cited by 74
Self-citationPharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
Seyedmousavi, S., Brüggemann, R. J. M., Meis, J. F. G. M., Melchers, W. J. G., Verweij, P. E., & Mouton, J. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04907-14 · Cited by 72
Self-citationArendrup, M. C., Hare, R. K., Grif, K., Skov, M., Pressler, T., Johansen, H. K., & Lass‐Flörl, C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis442 · Cited by 71
A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus
Paul, R. A., Rudramurthy, S. M., Meis, J. F. G. M., Mouton, J. W., & Chakrabarti, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00637-15 · Cited by 69
Self-citationAzole‐resistant Aspergillus fumigatus isolates carrying TR 34/L98H mutations in Taiwan
Wu, C., Wang, H., Lee, J., Lo, H., Dai, C.-T., Chou, P., Ko, W., & Chen, Y. (2015) · Mycoses · doi:10.1111/myc.12354 · Cited by 68
Lavergne, R., Chouaki, T., Hagen, F., Toublanc, B., Dupont, H., Jounieaux, V., Meis, J. F. G. M., Morio, F., & Pape, P. L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw664 · Cited by 66
Self-citationÖzmerdiven, G. E., Aksoy, S. A., Ener, B., Ağca, H., Cılo, B. D., Tunca, B., & Akalın, H. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.04.012 · Cited by 65
Ahmad, S., Joseph, L., Hagen, F., Meis, J. F. G. M., & Khan, Z. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku410 · Cited by 62
Self-citationJensen, R. H., Hagen, F., Astvad, K. M. T., Tyron, A., Meis, J. F. G. M., & Arendrup, M. C. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.001 · Cited by 61
Self-citationRapid Diagnosis of Azole-Resistant Aspergillosis by Direct PCR Using Tissue Specimens
van der Linden, J. W. M., Snelders, E., Arends, J. P., Daenen, S. M. G. J., Melchers, W. J. G., & Verweij, P. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02221-09 · Cited by 60
Self-citationMultiple Fungicide-Driven Alterations in Azole-ResistantAspergillus fumigatus, Colombia, 2015
Pape, P. L., Lavergne, R., Morio, F., & Álvarez, C. (2015) · Emerging infectious diseases · doi:10.3201/eid2201.150978 · Cited by 55
Lescar, J., Meyer, I., Akshita, K., Srinivasaraghavan, K., Verma, C., Palous, M., Mazier, D., Datry, A., & Fekkar, A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku316 · Cited by 54
Howard, S. J., Pasqualotto, A. C., Anderson, M. J., Leatherbarrow, H., Albarrag, A., Harrison, E., Gregson, L., Bowyer, P., & Denning, D. W. (2013) · Mycoses · doi:10.1111/myc.12047 · Cited by 54
Zhang, J., Debets, A. J. M., Verweij, P. E., Melchers, W. J. G., Zwaan, B. J., & Schoustra, S. E. (2015) · Evolution · doi:10.1111/evo.12763 · Cited by 54
Self-citationMulti-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan
Hagiwara, D., Takahashi, H., Fujimoto, M., Sugahara, M., Misawa, Y., Gonoi, T., Itoyama, S., Watanabe, A., & Kamei, K. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.01.015 · Cited by 51
Discovery of a Sexual Cycle in Aspergillus lentulus, a Close Relative of A. fumigatus
Swilaiman, S. S., O'Gorman, C. M., Balajee, S. A., & Dyer, P. S. (2013) · Eukaryotic Cell · doi:10.1128/ec.00040-13 · Cited by 50
Hiemenz, J., RAAD, I. I., Maertens, J., Hachem, R. Y., Saah, A. J., Sable, C. A., Chodakewitz, J., Severino, M. E., Saddier, P., Berman, R. S., et al. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1013-0 · Cited by 45
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection
Lazzarini, C., Esposto, M. C., Prigitano, A., Cogliati, M., Lorenzis, G. D., & Tortorano, A. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02234-15 · Cited by 45
Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection
Kolwijck, E., van der Hoeven, H., de Sévaux, R. G. L., ten Oever, J., Rijstenberg, L. L., van der Lee, H. A. L., Zoll, J., Melchers, W. J. G., & Verweij, P. E. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2104le · Cited by 44
Self-citationDiagnosis and management of aspergillosis in the Netherlands: a national survey
Lestrade, P. P. A., Meis, J. F. G. M., Arends, J. P., van der Beek, M. T., Brauwer, E. D., van Dijk, K., de Greeff, S. C., Haas, P., Hodiamont, C. J., Kuijper, E. J., et al. (2015) · Mycoses · doi:10.1111/myc.12440 · Cited by 41
Self-citationMavridou, E., Meletiadis, J., Jancura, P., Abbas, S., Arendrup, M. C., Melchers, W. J. G., Heskes, T., Mouton, J. W., & Verweij, P. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072280 · Cited by 39
Self-citationPeláez, T., Monteiro, M. C., Garcia‐Rubio, R., Bouza, E., Gómez‐López, A., & Mellado, E. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.04.005 · Cited by 39
Fitness Studies of Azole-Resistant Strains of Aspergillus fumigatus
Valsecchi, I., Mellado, E., Beau, R., Raj, S., & Latgé, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01594-15 · Cited by 37
Takahashi‐Nakaguchi, A., Muraosa, Y., Hagiwara, D., Sakai, K., Toyotome, T., Watanabe, A., Kawamoto, S., Kamei, K., Gonoi, T., & Takahashi, H. (2015) · Medical Mycology · doi:10.1093/mmy/myv003 · Cited by 36
Our 2015 approach to invasive pulmonary aspergillosis
Liss, B., Vehreschild, J. J., Bangard, C., Maintz, D. C., Frank, K. F., Grönke, S., Michels, G., Hamprecht, A. G., Wisplinghoff, H., Markiefka, B., et al. (2015) · Mycoses · doi:10.1111/myc.12319 · Cited by 31
Diversity and origins of Indian multi‐triazole resistant strains of Aspergillus fumigatus
Chang, H., Ashu, E. E., Sharma, C., Kathuria, S., Chowdhary, A., & Xu, J. (2016) · Mycoses · doi:10.1111/myc.12494 · Cited by 28
Self-citationBrillowska‐Dąbrowska, A., Mroczyńska, M., Nawrot, U., Włodarczyk, K., & Kurzyk, E. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1143 · Cited by 24
Microbial yield from physiotherapy assisted sputum production in respiratory outpatients
Langridge, P., Sheehan, R., & Denning, D. W. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0188-2 · Cited by 19
Cornely, O. A., Meems, L., Herbrecht, R., Viscoli, C., van Amsterdam, R. G. M., & Ruhnke, M. (2014) · Mycoses · doi:10.1111/myc.12274 · Cited by 17
de Fontbrune, F. S., Denis, B., Meunier, M., Garcia‐Hermoso, D., Bretagne, S., & Alanio, A. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12231 · Cited by 11
Cited by
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Self-citationThreats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture
Fisher, M. C., Gurr, S. J., Cuomo, C. A., Blehert, D. S., Jin, H., Stukenbrock, E. H., Stajich, J. E., Kahmann, R., Boone, C., Denning, D. W., et al. (2020) · mBio · doi:10.1128/mbio.00449-20 · Cited by 536
Self-citationRudramurthy, S. M., Paul, R. A., Chakrabarti, A., Mouton, J. W., & Meis, J. F. (2019) · Journal of Fungi · doi:10.3390/jof5030055 · Cited by 299
Self-citationAzole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment
Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix210 · Cited by 262
Self-citationAgarwal, R., Sehgal, I. S., Muthu, V., Denning, D. W., Chakrabarti, A., Soundappan, K., Garg, M., Rudramurthy, S. M., Dhooria, S., Armstrong-James, D., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.00061-2024 · Cited by 261
Self-citation
Metadata
- Authors
- Meis, J. F., Chowdhary, A., Rhodes, J. L., Fisher, M. C., & Verweij, P. E.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2016-12-05
- Volume
- 371
- Issue
- 1709
- Pages
- 20150460
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2535481478
- Cited by
- 308
- References
- 91
- FWCI
- 23.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.